Advertisement Biolase and Henry Schein renew distribution agreement - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Biolase and Henry Schein renew distribution agreement

Biolase Technology and Henry Schein have renewed and strengthened their multi-year distribution agreement in order to drive greater sales and better channel efficiency.

Under the renewed agreement, Biolase sales and service organizations will work closely with Henry Schein in the marketing, sales and service of all professional Biolase dental laser system products, including the Waterlase MD and ezlase diode laser system.

Under the revised agreement, Henry Schein remains the exclusive distributor of the complete line of Biolase dental laser systems, accessories and services within the US and Canada, and will augment essential promotion, sales, installation, service and support functions. The new agreement calls for certain commitments to sales and marketing investments and milestones, as well as performance guidelines. In addition, Biolase will provide training support to enable Henry Schein to provide basic services through its comprehensive service network. Biolase will also actively promote Henry Schein financial services as its exclusive leasing and financing partner.

Jake St. Philip, CEO of Biolase, said: “Both parties are now focused on how we can build on what we have learned in the past year and develop specific plans to improve market adoption, take costs out of the distribution network and continue to improve the local coordination between our sales teams.”